Pharm-Olam is now Allucent. Learn More
Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
Oncology is a multi-faceted field of study and a popular one. Cancer clinical trials account for more than 19% of the research...
Site location can have a significant impact on clinical trial success. Study protocols often have established timelines and...
Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer happened...
Rare oncology is a subset of Oncology that encompasses those cancers with the rarest incidence. They may be a common type like...
There are more than 7,000 rare diseases in existence right now and together they impact millions of people around the world....
Tags: Rare & Orphan Disease
Rare disease isn’t rare. As a whole, more than 350 million people in the world have at least one rare disease – more than the...
COVID-19 moved from a ubiquitous virus to a full-on pandemic very quickly. As countries and city centers took steps to stem the...
The onset of the COVID-19 pandemic has introduced a variety of challenges to “business as usual.” The virus and the ensuing risk...
Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, COVID-19
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
